文献速递耳科与耳神经

预测特发性突发性感音神经性听力损失患者听力恢复的预后模型

A Prognostic Model to Predict Hearing Recovery in Patients With Idiopathic Sudden Onset Sensorineural Hearing Loss.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2024-01-01

本研究利用英国76家国民健康服务(NHS)耳鼻咽喉科2019年12月至2022年5月收治的812例特发性突发性感音神经性听力损失(iSSNHL)患者队列数据,构建并内部验证听力完全恢复的预后模型,最终纳入498例,完全恢复210例(46%)。模型含5个独立预测因子,内部验证c-index为0.77(95%CI 0.7-0.81),校准良好,临床效用优于全部治疗或全不治疗策略。

要点

  • 模型含5个独立预测因子:7天内激素治疗、听力损失程度轻、无眩晕、年龄较轻、心血管疾病史。
  • 内部验证c-index为0.77(95%CI 0.7-0.81),预测完全恢复率与观察值一致。
  • 该模型可在线免费获取,可能帮助耳鼻咽喉科医生制定个体化治疗决策。

核心结论

  • 本研究评估的预后模型可能帮助耳鼻咽喉科医生为iSSNHL患者制定个体化治疗决策,模型可在线免费获取。

研究设计与样本

  • 预后研究与模型构建,使用突发性感音神经性听力损失研究的队列数据,纳入英国76家NHS耳鼻咽喉科2019年12月至2022年5月诊断的812例年龄≥16岁的iSSNHL患者。
  • 选取9个既往报告为iSSNHL完全恢复独立预后因素的变量,最终模型采用500次重复的bootstrap法进行内部验证,并校正系数乐观度,重新评估模型截距。
  • 数据分析于2022年3月至2024年4月进行。

主要发现

  • 最终纳入498例患者(平均[SD]年龄58.7[16.0]岁;女性215例[46.9%],男性243例[53.1%]),其中210例(46%)完全恢复。
  • 完全恢复的独立预测因素包括:症状出现7天内激素治疗(OR 5.23 vs 无治疗)、就诊时听力损失程度较轻(轻度损失OR 0.19)、无眩晕(OR 0.56 vs 无眩晕)、年龄较轻(每岁OR 0.64)、心血管疾病史(OR 1.84 vs 无心血管疾病)。
  • 内部验证后模型表现良好,c-index为0.77(95%CI 0.7-0.81),完全恢复的预测值与观察值吻合良好,临床效用优于全部治疗或全不治疗策略。

关键数值与推荐

  • 完全听力恢复定义为iSSNHL症状出现后6至16周,患耳所有频率听力水平恢复至发病前10 dB以内。
  • 常规治疗按NHS标准,包括口服激素和鼓室内激素注射。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The prognosis of idiopathic sudden onset sensorineural hearing loss (iSSNHL) is uncertain, which creates challenges in clinical decision-making for ear, nose, and throat (ENT) physicians and adds to the burden of the condition experienced by patients. OBJECTIVE: To develop and internally validate a prognostic model for hearing recovery among patients with iSSNHL to support ENT surgeons in making informed and individualized treatment decisions. DESIGN, SETTINGS, AND PARTICIPANTS: This prognostic study and model used cohort data from the Sudden Onset Sensorineural Hearing Loss study, which included 812 patients (age ≥16 years) diagnosed with iSSNHL at 76 National Health Service ENT departments in the UK from December 2019 to May 2022. Nine variables previously reported as independent prognostic factors for complete recovery of patients with iSSNHL were selected for inclusion. The final model was internally validated using bootstrapping with 500 repetitions, then coefficients were adjusted for the degree of optimism in the model. The model intercept was reassessed after adjustment of model coefficients. Impact of individual predictors was evaluated by estimating odds ratios with corresponding 95% CIs. Model performance was re-evaluated after internal validation and expressed by discrimination, calibration, and clinical utility. Data analyses were performed from March 2022 to April 2024. INTERVENTION: Routine treatment (per National Health Service standards), including oral steroids and intratympanic steroid injections. MAIN OUTCOME AND MEASURES: Complete hearing recovery defined as a return to within 10 dB of the patient's before iSSNHL hearing levels at all frequencies in the affected ear at 6 to 16 weeks after iSSNHL symptom onset. RESULTS: The study sample included 498 patients (mean [SD] age, 58.7 [16.0] years; 215 [46.9%] females and 243 [53.1%] males) who met the criteria for inclusion in the model. Of those, 210 (46%) were classified as having experienced complete hearing recovery. Five variables were found to be independent predictors for complete hearing recovery: steroid treatment within 7 days from symptom onset (OR, 5.23 vs no treatment ), lower severity of hearing loss at presentation (OR, 0.19 if loss is mild), absence of vertigo (OR, 0.56 vs no vertigo), younger patient age (OR, 0.64 per year), and a history of cardiovascular disease (OR, 1.84 vs no cardiovascular disease). The model showed good performance after internal validation with a c-index of 0.77 (95% CI, 0.7-0.81). Predictions for complete recovery aligned well with observed complete recovery rates, and greater clinical utility than treat all or treat none strategies was shown. CONCLUSION AND RELEVANCE: This prognostic model evaluated in this study may be able to assist ENT surgeons in making informed treatment decisions for individual patients with iSSNHL. It is available online at no cost.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Mandavia R, Joshi N, Hannink G, et al. A Prognostic Model to Predict Hearing Recovery in Patients With Idiopathic Sudden Onset Sensorineural Hearing Loss. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 39235820. doi:10.1001/jamaoto.2024.2598

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。